Stock Market

all prices

	price	high	low	%
Dow Jones	25400	25847	25367	-1.19 %
S&P500	3030	3069	3023	-0.53 %
Nasdaq 100	9423	9569	9325	-0.24 %
Euro Stoxx 50	3073	3102	3050	0.46 %
FTSE 100	6179	6229	6142	0.44 %
CAC40	4738	4786	4698	0.67 %
DAX	11693	11836	11655	-0.31 %
Hong Kong HSI	23234	23438	22735	1 %
Nikkei 225	21847	22110	21585	0.61 %

Live stock markets prices

15 min
1H
4H
Daily

Dow Jones	25402	-1.18%
S&P500	3030	-0.52%
Nasdaq 100	9424	-0.23%
FTSE 100	6179	0.44%

CAC40	4738	0.67%
Nikkei 225	21842	0.59%
Euro Stoxx 50	3073	0.46%
DAX	11693	-0.31%

Latest news

Thunderbird Entertainment Reports on Company Record Third Quarter Results

AEEC-Google COVID-19 Solutions

Kaiser Permanente Extends COVID-19 Cost Waiver Through Dec. 31, 2020

NexPoint Hospitality Trust To Postpone Reporting First Quarter 2020 Financial Results And MD&A Due To COVID-19 Related Delays

Pacific Workers', The Lawyers for Injured Workers Expands Amid COVID with Stockton & Sacramento Offices

Several Puerto Rico Golf Courses And Resorts Reopen

Fidelity National Financial And FGL Holdings Announce Preliminary Merger Consideration Election Results

Lilly Receives U.S. FDA Approval of TAUVID(TM) (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease

Susan C. Keating, CEO of WomenCorporateDirectors, Responds to Washington State's New Gender Diversity Board Mandate

Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

TSX Venture Exchange Stock Maintenance Bulletins

Endofotonics Raises S$12 million in Series B Funding for the Commercialization of its AI Powered Medical Device to Support Clinicians in the Real Time Detection of Early Stomach Cancer

Insoluble Dietary Fibers Market to Hit $5 Billion by 2026, Says Global Market Insights, Inc.

CNW Media Daybook for Friday, May 29, 2020

Universities Space Research Association Elects KAIST and Seoul National University to Membership

SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report

Notice to the media - Ministers and Government of Canada officials to hold a news conference on coronavirus disease (COVID-19)

Fieldex Exploration Grant Options

Solaris Completes C$20 Million Private Placement

Fiera Capital Corporation announces the election of directors

Thursday, 28 May 2020, 19:38

Thunderbird Entertainment Reports on Company Record Third Quarter Results

Third Quarter Revenue $29.3 million, increasing 40% over Q3 2019

Record Quarterly Adjusted EBITDA $6.9 million, increasing 45% over Q3 2019

Record Quarterly Free Cash flow of $4.5 million

Transformational shift in consumer behaviour leads to global record streaming

Remote working structures for 1,000-plus team members provide increased capacity to scale-up to meet high growth demand for premium content

Balance sheet further strengthened through final payment made on RBC term loan, company is debt free with $12.2M of cash

Conference call and webcast scheduled for June 1 at 2 p.m. ET

VANCOUVER, May 28, 2020 /PRNewswire/ - Thunderbird Entertainment Group Inc. (TSXV:TBRD, OTC - THBRF) (Thunderbird or the Company), today announced its financial results for the third quarter ended March 31, 2020, and provided a corporate update.

Financial Highlights

Revenue for the three and nine months ended March 31, 2020 was $29.3 million and $59.6 million compared to $20.9 million and $44.7 million for the comparative periods in fiscal 2019.
Adjusted EBITDA was $6.9 million and $11.2 million for the three and nine months ended March 31, 2020 compared to $4.7 million and $10.3 million for the comparative periods in fiscal 2019.
Net income from continuing operations was $3.2 million and $3.2 million for the three and nine months ended March 31, 2020, compared to $2.1 million and net loss from continuing operations of $2.6 million for the comparative periods of 2019.
The Company generated free cash flow of $4.5 million for the three months ended March 31, 2020, after retiring the balance of a $6 million term loan provided by the Royal Bank of Canada in 2018.

"With substantial increases in Thunderbird's YOY Q3 2020 revenue, as well as its record AEBITDA, Thunderbird demonstrates its resilience and high growth business model. Throughout COVID-19, the Company has continued to grow and deliver industry leading results, with Q3 being Thunderbird's best quarter to date," said Brian Paes-Braga, Chairman, Thunderbird Entertainment. "All of this is further complemented with record free cash flow generation from the quarter of more than $4.5 million and a balance sheet that is not only in exceptional shape, but will also open up new opportunities for disciplined M&A."

"Thunderbird's unique business model allows the Company to thrive," Paes-Braga added. "By remaining fully operational, Thunderbird has created new roles and hired additional team members to meet new demand from buyers looking to fill schedules with premium quality content. This is a testament to the leadership of the management team during this global crisis."

As of March 30, Thunderbird's team of more than 1,000 crew members across all divisions in Vancouver, Los Angeles, Ottawa and Toronto were set up to work remotely. The Company's quick actions allowed for work to continue, and all productions in development are moving forward. Thunderbird continues to pitch, develop, produce, sell, deliver and service content to its partners including Netflix, NBCUniversal, Nickelodeon, PBS, WGBH, Bell Media's Discovery, APTN, Corus Entertainment, the Weather Channel, and the CBC, among others.

Key Responses and Impacts of COVID-19

Early Anticipation of Pandemic Facilitated Quick Transition to Remote Working: Pre-emptive actions, in conjunction with the Company's strong balance sheet with virtually no corporate debt, enabled Thunderbird to transition its workforce of more than 1,000 crew to work from home to ensure safety.

Emphasis on Mental Health and Well-being for Employees in Self-isolation: Prioritizing the health of its team, Thunderbird also deployed new health and well-being initiatives to support employees and their families in self-isolation, including the availability of mental health and wellness resources available 24/7.

Leveraging Cutting-Edge Technology to Support Business Continuity: The pandemic has accelerated the already heightened demand for content, with an 85% increase in consumption in March 2020, according to a Nielsen report. Investment in technology, including a new firewall and 800 licenses from Teradici, enabled all productions in various stages of development and production to move forward. This, together with new filming techniques, also allowed factual productions to continue in adherence to physical distancing guidelines.

Strong Relationships with Valued Industry Partners Contribute to Ongoing Workflow: The Company has, and continues to receive, indications from traditional broadcasters and streaming partners (including Netflix, Disney+, NBCUniversal) that they will need more content on an ongoing basis to keep up with demand, which is anticipated to continue following the pandemic. The Company hired and virtually onboarded 30 new team members to support the increased workflow since April 1, 2020.

Continued Scenario Planning: The Company has undergone extensive planning across all divisions and productions to safeguard the business while economies reopen globally. This involves everything from reconfiguring studio spaces for future use, to creating business continuity plans for all productions in development.

"As creators during the pandemic, our work has taken on new meaning, and knowing that Thunderbird's content has played even a small role in keeping families entertained is humbling," said Jennifer Twiner McCarron, CEO of Thunderbird. "Digital technology enabled the Company to prioritize the health of our team and make a pivotal shift at a time when demand for content is soaring. Thunderbird is entering a whole new paradigm, and the investments we've made in infrastructure and our team, uniquely position the Company to keep delivering premium content, while also providing us with the opportunity to scale-up like never before."

Results of Operations
Results for the three and nine months ended March 31, 2020 compared to the three and nine months ended March 31, 2019:


	Three months ended		Nine months ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
($000's, except per share data)	$	$	$	$

Revenue	29,301	20,946	59,550	44,736
Expenses¹	26,141	18,828	56,305	47,310
Net income (loss) from continuing operations	3,160	2,118	3,245	(2,574)
Loss from discontinued operations	(205)	(189)	(773)	(152)
Net income (loss) for the period	2,955	1,929	2,472	(2,726)
¹Expenses includes a charge related to Public company listing of $5,316 in the nine months ended March 31, 2019

EBITDA, Adjusted EBITDA and Free Cash Flow are summarized as follows:

EBITDA	6,881	4,288	11,123	8,369
Adjusted EBITDA	6,881	4,734	11,236	10,269
Free Cash Flow	4,472	(1,532)	4,700	(1,630)

Consolidated revenue for the three and nine months ended March 31, 2020 was $29.3 million and $59.6 million as compared to $20.9 million and $44.7 million for the comparative periods of fiscal 2019, increases of $8.4 million and $14.9 million respectively. The majority of this revenue increase over the comparative periods in 2019 related to growth in the kids and family division.
Consolidated net income from continuing operations was $3.2 million and $3.2 million for the three and nine months ended March 31, 2020, compared to net income from continuing operations of $2.1 and net loss from continuing operations of $2.6 million for the comparative periods of fiscal 2019. Net income was $3.0 million and $2.5 million, after loss from discontinued operations of $205 and $773, as compared to net income of $1.9 million and a net loss of $2.7 million after loss from discontinued operations of $189 and $152 in the previous periods of 2019. The Company incurred a one-time charge during the comparative period of fiscal 2019 relating to the RTO Transaction of $5.3 million.
Adjusted EBITDA was $6.9 million and $11.2 million for the three and nine months ended March 31, 2020 compared to $4.7 million and $10.3 million for the comparative periods of fiscal 2019, an increase of $2.2 million and $0.9 million, respectively. The three month increase was due to a large increase in production service work, as well as an increase in licensing and distribution revenues due to an increase in the number of proprietary shows delivered over the comparable quarter. This was offset by the related increase in direct costs and amortization of content due to those shows and also increases in salaries, contracting and computer software due to significant growth in the animation and factual divisions. There was also a decrease in rent expense primarily due to the adoption of IFRS 16 in which lease obligations for long-term leases are no longer recorded as rent expense, but capitalized as right-of-use ("ROU") assets and amortized.
During the quarter, management decided to discontinue operations of its UK division. The related assets and liabilities have been presented as held for sale, and the net revenues and expenses are shown as a loss from discontinued operations.
During the six months ended December 31, 2019, the Company paid down the remaining $1.4 million of a three-year non-revolving term loan that was initially drawn in July 2018 in the amount of $6.0 million. The term loan was drawn in order to repurchase common shares of certain shareholders of Thunderbird and was part of an overall credit facility negotiated with the Royal Bank of Canada that also included an increased production line of credit and an acquisition facility.

The Company's unaudited interim financial statements, along with its Management's Discussion and Analysis for Q3 2020, are available on the Company's website at www.thunderbird.tv and under the Company's profile at www.sedar.com.

Thunderbird's Q3 Corporate Highlights

During the third quarter, the Company had 20 programs in various stages of production, and deals with Netflix, NBCUniversal, Nickelodeon, PBS, WGBH, Bell Media's Discovery, APTN, Corus Entertainment and CBC, among others.
Forty-three half-hour episodes and 21 one-hour episodes were delivered collectively in Q3 from the factual, scripted, and kids and family divisions. All of the one-hour episodes, and 24 of the half-hour episodes were Company IP.
Subsequent to the quarter, the IP-owned animated youth series The Last Kids on Earth received a nomination for a Daytime Emmy in the Outstanding Special Class Animated Program category.
Molly of Denali was selected as a finalist for PRIX JEUNESSE INTERNATIONAL 2020.
Molly of Denali was also recently nominated for an esteemed Peabody Award, being one of only two nominees in the children and youth category.
The Company received 11 nominations for the 2020 Canadian Screen Awards, and 20 Leo Award nominations.
The Company was named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2020, earning the standing of #9 in the Film and Television category.
The Company expanded its kids and family division with the opening of its Los Angeles animation studio. The LA studio's first project is already in production with 80 crew working remotely.
The Company presented at the third annual LD Micro Virtual Conference, and virtually attended the 32nd Annual ROTH Conference.
Technology, with the new working remotely environment, provides new opportunities for the Company to scale-up to meet the increased demand for content and take-on more work.

Division Updates
Factual Division, Great Pacific Media

During the quarter, Thunderbird's factual division was in production on six series and one documentary special: Highway Thru Hell (Season 9), Heavy Rescue: 401 (Season 5), $ave My Reno (Season 3), Queen of the Oil Patch (Season 2), High Arctic Haulers (Season 1), Untitled Factual Series (Season 1), and The Teenager and the Lost Mayan City (Documentary for CBC).
Highway Thru Hell (Season 9) completed principal photography on the series' largest season to date, with 18 one-hour episodes. The new episodes will premiere in the fall of 2020.
Heavy Rescue: 401 (Season 5) completed principal photography in the quarter. Season 5 will feature 18 one-hour episodes and is scheduled to premiere in January 2021.
Season 2 of the critically-acclaimed documentary series Queen of the Oil Patch wrapped post production, with eight episodes being produced. The series is produced in collaboration with Kah-Kitowak Films. It is scheduled to premiere June 7, 2020 on APTN.
The Company also premiered its newest high-action factual series, High Arctic Haulers, in partnership with the CBC. High Arctic Haulers premiered on CBC in January 2020. Thunderbird holds worldwide rights to the original IP series and will be launching it to foreign markets with Beyond Distribution.
$ave My Reno (Season 3) premiered on HGTV Canada in the quarter and generated impressive ratings. The title was renewed for a fourth season consisting of 14 episodes for Corus Entertainment.
The Teenager and the Lost Mayan City continued principal photography in Quebec and Mexico for CBC's The Nature of Things.
The Company began principal photography on an exciting new series for Canadian and international broadcasters. "Untitled Factual Series" (Season 1) will consist of eight hour-long episodes and will premiere in the 2020/21 broadcast season.

Kids & Family Division, Atomic Cartoons

During the quarter, Atomic Cartoons was in various stages of production on 14 animated series. Service productions include Hello Ninja and Mighty Express for Netflix, Molly of Denali for WGBH/ PBS KIDS and CBC, 101 Dalmatian Street for Disney+, and LEGO Jurassic World for NBCUniversal.
Subsequent to the quarter, the second season of the IP-owned animated youth series The Last Kids on Earth launched on April 17, exclusively on Netflix. Available in 190 countries, it featured 10 new episodes, and more episodes are in production, including an interactive special. The Last Kids on Earth is based on the hugely popular New York Times best-selling book series of the same name, written by Max Brallier. In addition, the highly-anticipated toy line based on the series is now available. A t-shirt line has also launched and a video game is in development for a 2021 debut.
A new partnership was announced between Atomic and the visionary Jim Henson Company, to develop a new animated series called Nate Create. The production will feature a variety of art styles like origami, watercolor, 2D, cut-out, stop-motion, and CG, and will be one of the division's most ambitious series.
Also, subsequent to the quarter, the second season of Hello Ninja began streaming on Netflix on April 24, 2020 in 28 languages and 190 countries. A third season for this popular series was announced in May 2020.
The Company announced it was in production of a new CG-animated series for preschoolers called Mighty Express. This series was announced in February by Netflix and Spin Master, which is renowned for many hit series, including the popular Paw Patrol franchise.
The Company also produces short films for Disney. To date, Marvel Super Heroes has received more than 240 million views on the Youtube channel, and has similarly high numbers on the Disney Junior channel. The Black Panther short film passed 20 million views in March.

Scripted Division

Subsequent to the quarter, the fourth season of Kim's Convenience began streaming April 1 on Netflix outside of Canada (it remains available in Canada on CBC Gem). Kim's Convenience was also renewed for seasons five and six, which are scheduled for 2021 and 2022 respectively. The series was also included by TV Guide in its April 2020 ranking of the best feel-good series currently available on Netflix, Amazon, Hulu, and Disney+.
The team working on Kim's Convenience are currently in the writers' room, working remotely on scripts for the two upcoming seasons.

Conference Call Webcast on June 1, 2020 at 2 p.m. Eastern Standard Time
Thunderbird will hold a conference call and webcast to share the Company's third quarter financial results on June 1, 2020 at 11 a.m. PST/ 2 p.m. EST. A live webcast of the conference call can be accessed by clicking here. The call will be recorded for webcasting purposes and will be available at www.thunderbird.tv two hours after the initial scheduled time.

Q3 Conference Call: Monday, June 1, 2020 at 11 a.m. PST/ 2 p.m. EST
Canadian Dial-In Numbers: (+1) 416-764-8688 (Toronto), (+1) 778-383-7413 (Vancouver)
North American Toll-Free Number: (+1) 888-390-0546

Alternatively, you may access a replay of the conference call by calling (+1) 416-764-8677 or toll-free at (+1) 888-390-0541 (passcode 178213 #) two hours after the initial scheduled time.

For information on Thunderbird and to subscribe to the Company's investor list for news updates, go to www.thunderbird.tv.

About Thunderbird Entertainment Group
Thunderbird Entertainment Group is a global award-winning, full-service, multiplatform production, distribution, and rights management company, headquartered in Vancouver, with additional offices in Los Angeles, Toronto, and Ottawa. Thunderbird creates award-winning scripted, unscripted, and animated programming for the world's leading digital platforms, as well as Canadian and international broadcasters. Thunderbird's vision is to produce high quality, socially responsible content that makes the world a better place. The Company develops, produces, and distributes animated, factual, and scripted content through its various divisions, including Thunderbird kids and family (Atomic Cartoons), Thunderbird factual (Great Pacific Media) and Thunderbird productions. Thunderbird is on Facebook, Twitter, and Instagram at @tbirdent. For more information, visit: www.thunderbird.tv.

On Behalf of Thunderbird Entertainment Group Inc.

Jennifer Twiner McCarron
Chief Executive Officer

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility of the adequacy or accuracy of this release, which has been prepared by management.

Cautionary Statement Regarding Forward-Looking Information
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, statements with respect to the Company's objectives, goals or future plans and the business and operations of the Company. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; those additional risks set out in the Company's Filing Statement and other public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

Non-IFRS Measures
This news release contains references to certain measures that do not have a standardized meaning under International Financial Reporting Standards ("IFRS") as prescribed by the International Accounting Standards Board and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS measures by providing a further understanding of operations from management's perspective. Accordingly, non-IFRS measures should not be considered in isolation nor as a substitute for analysis of financial information reported under IFRS. The Company believes that non-IFRS measures, specifically EBITDA and Adjusted EBITDA, are frequently used by securities analysts, investors and other interested parties as measures of financial performance and to provide supplemental measures of operating performance and thus highlight trends that may not otherwise be apparent when relying solely on IFRS financial measures.

View original content to download multimedia:http://www.prnewswire.com/news-releases/thunderbird-entertainment-reports-on-company-record-third-quarter-results-301067453.html

SOURCE Thunderbird Entertainment Group Inc.

Thursday, 28 May 2020, 19:36

AEEC-Google COVID-19 Solutions

RESTON, Va., May 28, 2020 /PRNewswire/ -- AEEC, a Virginia based technology company, in collaboration with Google Cloud, has developed two technology solutions to enable Americans to "Flatten the COVID-19 Curve" using real time, scientific, and geocoded data generated from social media, public, and private organizations.

"Flatten the Curve" Web Application: The mobile application will convey information for the public, health professionals, and policymakers in enhancing case detection, enabling digital contact tracing, and acting as a data capture portal for critical health data associated with COVID-19 and analyzed within Google Cloud Platform. It is built to deliver evidence-based public health interventions and inform the public about needed measures to avoid disease transmission.

"Flatten the Curve" Web Application

Environmental Surface Sampling: AEEC has developed a COVID-19 surface sampling process based on our experience from 2001 Anthrax sampling across the country. We have created a test platform for detecting the presence of viruses, such as COVID-19, using the methodology from the CDC's 2019-nCOV Real-Time RT-PCR Diagnostic protocol. Our solution assesses and determines the extent of surface contamination and provides an assurance for effective cleaning to eliminate presence of any COVID-19 at work locations or public areas. The test platform, including data storage, risk assessment results, data analytics, and chain of custody of samples are all managed in a secured Google Cloud environment.

Environmental Surface Sampling

Contact: info@americanconsultants.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/aeec-google-covid-19-solutions-301067452.html

SOURCE AEEC, LLC

Thursday, 28 May 2020, 19:30

Kaiser Permanente Extends COVID-19 Cost Waiver Through Dec. 31, 2020

OAKLAND, Calif., May 28, 2020 /PRNewswire/ -- Kaiser Permanente has announced that it will extend its waiver for most member out-of-pocket costs for inpatient and outpatient services related to the treatment of COVID-19 through December 31, 2020. This waiver, put into effect on April 1 and originally set to expire on May 31, is intended to alleviate the cost burden and stress of paying for care, allowing members to focus on recovery.

"Kaiser Permanente understands the financial impact that COVID-19 has had on our members and the communities we serve and is committed to ensuring they have access to the care they need during this time of crisis," said Greg Adams, chairman and CEO of Kaiser Permanente. "This move aims to alleviate any stress about paying for care, as well as any hesitancy to seek needed care. The path forward through this pandemic must include identifying, treating and tracing as many cases of COVID-19 as possible as we work to suppress this virus."

Kaiser Permanente's elimination of member out-of-pocket costs applies to all fully insured benefit plans, in all markets, unless prohibited or modified by law or regulation. It will apply for all dates of service from April 1 through December 31, 2020, unless superseded by government action or extended by Kaiser Permanente. This waiver does not automatically apply to self-funded customers who directly administer health benefits to their employees. It also does not cover out of network care for choice product members, unless urgent or emergency care. Kaiser Permanente has encouraged self-funded customers to adopt this change.

Kaiser Permanente suspended all terminations for nonpayment of premium or out-of-pocket expenses from March 15 through May 31. In May, Kaiser Permanente further extended the suspension of terminations for nonpayment through June 30 for Kaiser Permanente for Individuals and Families and small group members.

About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 12.4 million members in eight states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health.

For more information, contact:
Marc Brown, marc.t.brown@kp.org

View original content to download multimedia:http://www.prnewswire.com/news-releases/kaiser-permanente-extends-covid-19-cost-waiver-through-dec-31-2020-301067444.html

SOURCE Kaiser Permanente

Thursday, 28 May 2020, 19:30

NexPoint Hospitality Trust To Postpone Reporting First Quarter 2020 Financial Results And MD&A Due To COVID-19 Related Delays

DALLAS and TORONTO, May 28, 2020 /PRNewswire/ -- NexPoint Hospitality Trust ("NHT") (TSX-V: NHT.U) announced today that it will be relying on Ontario Instrument 51-502 – Temporary Exemption from Certain Corporate Finance Requirements in respect of its obligation to file its interim financial statements for the first quarter of 2020 required by subsection 4.4 of National Instrument 51-102 – Continuous Disclosure Obligations ("NI 51-102") and its interim management's discussion and analysis required by subsection 5.1(2) of NI 51-102. NHT's management expects that the first quarter 2020 financial results and management's discussion and analysis will be filed on or about July 13, 2020. NHT's management and other insiders are subject to an insider trading black-out policy that reflects the principles in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

NHT is also postponing the filing of its executive compensation disclosure until a date on or before December 31, 2020 in reliance on the exemption under Ontario Instrument 51-504 – Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials, which instrument became effective as of May 1, 2020.

Since the filing of NHT's annual financial statements on May 26, 2020, there have not been any material developments.

About NexPoint Hospitality Trust

NexPoint Hospitality Trust is a publicly traded real estate investment trust, with its units listed on the TSX Venture Exchange under the ticker NHT.U. NHT is focused on acquiring, owning and operating well located hospitality properties in the United States that offer a high current yield and in many cases, that are underperforming assets with the potential to increase in value through investments in capital improvements, a market-based recovery, brand repositioning, revenue enhancements, operational improvements, reducing expense inefficiencies, and exploiting excess land or underutilized space. NHT owns 11 branded properties sponsored by Marriott, Hilton and InterContinental Hotels Group, located across the U.S., specifically in the Seattle, Portland, Dallas, Nashville and St. Petersburg markets. NHT is externally advised by NexPoint Real Estate Advisors VI, L.P. For more information, visit www.nexpointhospitality.com.

Cautionary Statement Regarding Forward-Looking Information

Certain statements in this press release may constitute "forward-looking" information that involves known and unknown risks, uncertainties and other factors, and it may cause actual results, performance or achievements or industry results, to be materially different from any future results, performance or achievements or industry results expressed or implied by such forward-looking information. Forward-looking information is identified by the use of terms and phrases such as "anticipate", "believe", "could", "estimate", "expect", "intend", "may", "plan", "predict", "project", "will", "would", and similar terms and phrases, including references to assumptions.

Forward-looking information contained in this press release is based on certain key expectations and assumptions by NHT. Although the forward-looking information contained in this press release is based upon what NHT's management believes to be reasonable assumptions, NHT cannot assure investors that actual results will be consistent with such information. Forward-looking information reflects current expectations of management regarding future events and operating performance as of the date of this press release. Such information involves significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking information, and a description of these factors can be found under "Risk Factors" in NHT's final prospectus dated March 27, 2019, Management's Discussion and Analysis dated May 26, 2020, and base shelf prospectus dated November 15, 2019, which are available on SEDAR (www.sedar.com).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
Investor Relations
Jackie Graham
972-628-4024
jgraham@nexpointadvisors.com

Chief Financial Officer
Brian Mitts
972-419-2556
BMitts@nexpointadvisors.com

Media Inquiries
MediaRelations@nexpointadvisors.com

SOURCE NexPoint Hospitality Trust

Thursday, 28 May 2020, 19:27

Pacific Workers', The Lawyers for Injured Workers Expands Amid COVID with Stockton & Sacramento Offices

OAKLAND, Calif., May 28, 2020 /PRNewswire/ -- Stockton, California, and Sacramento, California. Both offices were opened in late April of this year, during the COVID-19 pandemic.

Recently, Governor Gavin Newsom issued an executive order giving enhanced protections to Essential Workers from COVID-19.

Pacific Workers' core clients are Essential Workers —Firefighters, Peace Officers, Health Care Workers, and other frontline workers. Governor Newsom's order creating a presumption for workers' compensation coverage for Essential Workers has driven demand for more representation for the clients we serve.

Pacific Workers' already represents clients throughout Northern California, covering every Workers' Compensation Appeals Board and all Civil Courts.

"We were seeing more and more calls from essential injured workers throughout both of these areas," said Bilal Kassem, Managing Attorney of Pacific Workers'. "We simply want to better serve our clients and their families with a physical presence in these areas."

The new Stockton and Sacramento offices are likely temporary spaces until Pacific Workers' finds more permanent space.

Pacific Workers' has always valued the communities it serves, supporting various community organizations that help the most vulnerable. Pacific Workers', through the self-funded Pacific Workers' Foundation, donates and assists with manpower for various organizations such as the Oakland 55 Firefighters Union and the non-profit organization Best Buddies.

Currently, Pacific Workers' has decided to donate 5000 masks to community organizations, to get free reusable masks to the most vulnerable.

As the company expands its presence in Northern California, it will continue to reach out to more organizations that help the most vulnerable of our society and continue to contribute.

About the Company:

Pacific Workers', The Lawyers for Injured Workers is Northern California's Premier Workers' Compensation and Personal Injury Law Firm. They represent First Responders, Health Care Workers, Construction Workers, Delivery Workers, Warehouse Workers and the other hard-working people that keep our community moving in their Fight for Justice against the Insurance Companies.

Founded in 2014 by Eric Farber and Bilal Kassem, the firm began with just 4 people. In just over five years, they have grown to close to 50 team members. They have been named to the Inc. 5000 multiple times, the Bay Area 100 (a list of fastest growing companies in the Bay Area), the Law Firm 500 and most importantly been nominated for Best Workplaces in America. Mr. Farber is also the author of the Bestselling Book, The Case for Culture, How to Stop Being a Slave to Your Law Firm, Grow Your Practice and Actually Be Happy. The book is the story of how a great law firm culture can help grow a practice.

At the beginning of the pandemic, Pacific Workers' has joined the national small business No Layoff Pledge, agreeing to not lay any team members off to June. On the contrary, Pacific Workers' has actually hired several people for their expansion.

www.PacificWorkers.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/pacific-workers-the-lawyers-for-injured-workers-expands-amid-covid-with-stockton--sacramento-offices-301067448.html

SOURCE Pacific Workers' Compensation Law Center

Thursday, 28 May 2020, 19:25

Several Puerto Rico Golf Courses And Resorts Reopen

SAN JUAN, Puerto Rico, May 28, 2020 /PRNewswire/ -- Many of Puerto Rico's 18 golf courses have reopened, as recently announced by Gov. Wanda Vázquez.

Caution, patience, and discipline have been staples of the Island's proactive edicts designed to protect Puerto Rico residents and visitors. That will continue when many businesses gradually reopen across the Island. A 7 pm to 5 am curfew will remain in place until June 15, and all people will be required to wear a mask when outside or inside a business.

Puerto Rico, an American territory, will join the rest of the United States as pertains to the game; golf courses have reopened in all 50 states.

Some Island courses are open to everyone, including Royal Isabela, Club Deportivo del Oeste, and more. Other Island courses are open to members only currently – TPC Dorado Beach, Palmas Athletic Club, and Wyndham Grand Rio Mar, for example – with the public expected to be welcomed back imminently. For details pertaining to each golf venue, see the phone numbers listed below.

Courses have installed safeguards to enhance safe recreation, including staff using personal protective gear, sanitizing golf carts and the Pro Shop common areas throughout the day, and many more.

Puerto Rico's 18 golf courses are located throughout the Island – from the northwestern tip to the East Coast – with several in northeastern Puerto Rico near capital San Juan. The Island is an enchanting destination where history, culture, gastronomy, nightlife, beaches, hotels and resorts abound. It requires no passport for American citizens, is bilingual, uses the U.S. dollar for currency, and is the air hub of the Caribbean. There are more than 4,000 restaurants, and the lodging venues range from top hospitality brands to being named a top 10 Airbnb world destination.

The Island's golf venues include:
TPC Dorado Beach (36 holes) – 787-626-1020
Costa Caribe (27) – 787-812-2650
Fort Buchanan (9) – 787-707-3980
Wyndham Grand Rio Mar (36) – 787-888-6000
Rio Bayamon (18) – 787-740-1419
Hyatt Regency Grand Reserve/Coco Beach (36) – 787-657-2000
The St. Regis Bahia Beach (18) – 787-809-8000
Caguas Real (18) – 787-653-1573
Royal Isabela (18) – 787-609-5888
Deportivo del Oeste (18) – 787-851-8880
Palmas Athletic Club (36) – 787-656-3000
Punta Borinquen (18) – 787-890-2987
El Legado (18) – 787-866-8894
El Conquistador (18) – 787-863-1000

For more information on Island golf courses, resorts, and other destination attractions along with Puerto Rico's new health and safety guidelines visit: DiscoverPuertoRico.com.

Contact: Dan Shepherd
danshepherdpr@gmail.com
(703) 403-5317

View original content to download multimedia:http://www.prnewswire.com/news-releases/several-puerto-rico-golf-courses-and-resorts-reopen-301067446.html

SOURCE Discover Puerto Rico

Thursday, 28 May 2020, 19:23

Fidelity National Financial And FGL Holdings Announce Preliminary Merger Consideration Election Results

JACKSONVILLE, Fla. and GEORGE TOWN, Cayman Islands, May 28, 2020 /PRNewswire/ -- Fidelity National Financial, Inc. ("FNF") (NYSE: FNF) and FGL Holdings ("F&G") (NYSE: FG) today announced the preliminary results of the elections made by F&G shareholders regarding the form of merger consideration they wish to receive pursuant to the previously announced merger agreement pursuant to which FNF will acquire F&G. As previously announced, the deadline for making this election was 5:00 p.m. (Eastern time) on Wednesday, May 27, 2020 (the "election deadline").

As previously announced, F&G shareholders were able to elect to receive, without interest and subject to any required withholding of taxes, (i) $12.50 in cash (the "cash consideration") or (ii) 0.2558 shares of FNF common stock (the "stock consideration") per F&G share. All elections for cash consideration and stock consideration are subject to potential proration and adjustment as set forth in the merger agreement and election materials. The greater the oversubscription of the stock election, the fewer shares and more cash a F&G shareholder making the stock election will receive. Reciprocally, the greater the oversubscription of the cash election, the less cash and more FNF common stock a F&G shareholder making the cash election will receive. Such procedures are designed to ensure that the aggregate amount of cash consideration does not exceed $1,471,936,485.

Based on the available information as of the election deadline, the preliminary election results were:

Holders of 176,352,291 F&G ordinary shares, representing approximately 87.8% of the 200,758,987 outstanding F&G ordinary shares that were entitled to make an election pursuant to the merger agreement, elected to receive the cash consideration (the "cash election shares").
Holders of 3,488,854 F&G ordinary shares, representing approximately 1.7% of the 200,758,987 outstanding F&G ordinary shares that were entitled to make an election pursuant to the merger agreement, elected to receive the stock consideration (the "stock election shares").
Holders of 20,917,842 F&G ordinary shares, representing approximately 10.5% of the 200,758,987 outstanding F&G ordinary shares that were entitled to make an election pursuant to the merger agreement, did not make an election.

The foregoing results are preliminary only, and final certified results are not expected to be available until shortly before closing.

Based on the preliminary results described above, there was an oversubscription of the cash election. Therefore, the cash election shares are expected to be converted into the right to receive a combination of stock consideration and cash consideration, and the stock election shares and any shares with respect to which an election was not made prior to the election deadline are expected to be converted into the right to receive all stock consideration, pursuant to the terms set forth in the merger agreement. After the final results of the merger consideration election process are determined, the final allocation and proration of merger consideration will be calculated in accordance with the terms of the merger agreement.

A press release announcing the final election results and merger consideration will be issued after the final consideration is determined.

The extraordinary general meeting of F&G shareholders is scheduled to be held virtually on May 29, 2020. The anticipated closing date for the transaction is June 1, 2020, assuming that F&G shareholders approve the mergers and related proposals at the extraordinary general meeting, and subject to the satisfaction or waiver of customary conditions at the closing.

About Fidelity National Financial, Inc.

Fidelity National Financial, Inc. (NYSE: FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries. FNF is the nation's largest title insurance company through its title insurance underwriters - Fidelity National Title, Chicago Title, Commonwealth Land Title, Alamo Title and National Title of New York - that collectively issue more title insurance policies than any other title company in the United States. More information about FNF can be found at fnf.com.

About FGL Holdings

FGL Holdings-the F&G family of insurance companies-is committed to helping Americans prepare for and live comfortably in their retirement. Through its subsidiaries, F&G is a leading provider of annuity and life insurance products. FGL Holdings, domiciled in the Cayman Islands, trades on the New York Stock Exchange under the ticker symbol FG. For more information, please visit www.fglife.bm.

Cautionary Note Regarding Forward-Looking Statements

"Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements relating to F&G and FNF, including statements relating to the proposed transaction and related matters. Such statements are subject to risks and uncertainties, many of which are beyond the control of F&G and FNF, that could cause actual results, events and developments to differ materially from those set forth in, or implied by, such statements. These statements are based on the beliefs and assumptions of the management of F&G and FNF, respectively. Forward-looking statements are generally identifiable by use of the words "believes," "expects," "intends," "anticipates," "plans," "seeks," "estimates," "projects," "may," "will," "could," "might," or "continues" or similar expressions. Factors that could cause actual results, events and developments to differ include, without limitation: (1) changes in general economic, business and political conditions, including changes in the financial markets; (2) the outcome of any legal proceedings that may be instituted against F&G or FNF following the announcement of the merger agreement and the transactions contemplated therein; (3) the inability to complete the transactions contemplated by the merger agreement, including due to failure to obtain approval of the shareholders of F&G or other conditions to closing in the merger agreement; (4) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement or could otherwise cause the transactions contemplated by the merger agreement to fail to close; (5) the risk that the transactions contemplated by the merger agreement disrupt current plans and operations of F&G or FNF as a result of the announcement thereof; (6) the ability to recognize the anticipated benefits of the transactions contemplated by the merger agreement, which may be affected by, among other things, competition, the ability of the management of F&G and FNF to grow and manage their respective businesses profitably and to retain their key employees; (7) costs related to the transactions contemplated by the merger agreement; (8) changes in applicable laws or regulations; (9) the risk that the mergers may not be treated as a single integrated transaction that qualifies as a "reorganization" under Section 368(a) of the Internal Revenue Code of 1986, as amended, in which case the transactions contemplated by the merger agreement would be treated as a taxable sale by U.S. Holders of their F&G shares in exchange for the merger consideration; (10) adverse legal and regulatory developments or determinations or adverse changes in, or interpretations of, U.S. or other foreign laws, rules or regulations, including tax laws, rules and regulations, that could delay or prevent completion of the transactions contemplated by the merger agreement, cause the terms of such transactions to be modified or change the anticipated tax consequences of such transactions; (11) the possibility that F&G or FNF may be adversely affected by other economic, business, and/or competitive factors, as well as the impact on the business, operations, results of operations and trading prices of the shares of F&G and FNF arising out of the COVID-19 outbreak; (12) risks that any of the closing conditions to the proposed merger may not be satisfied in a timely manner; (13) the risk that the businesses will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the acquisition will not be realized; and (14) other risks and uncertainties identified in F&G's and FNF's filings with the U.S. Securities and Exchange Commission (the "SEC"). Each of F&G and FNF cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Neither F&G nor FNF undertakes or accepts any obligation or undertaking to release any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law. The information contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.

All forward-looking statements described herein are qualified by these cautionary statements and there can be no assurance that the actual results, events or developments referenced herein will occur or be realized. Neither F&G nor FNF undertakes any obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results, except as required by law.

Additional Information about the Proposed Transaction and Where to Find It

This press release relates to a proposed transaction between F&G and FNF, which is the subject of a registration statement and relevant solicitation materials filed by FNF with the SEC. In connection with the proposed transaction, FNF has filed with the SEC a registration statement on Form S-4 that includes a proxy statement of F&G and a prospectus of FNF, as well as other relevant documents concerning the proposed transaction. F&G commenced mailing of the definitive proxy statement to F&G's shareholders on April 30, 2020. This press release is not a substitute for the registration statement, the definitive proxy statement and relevant solicitation materials that FNF has or may file with the SEC or any other documents which FNF may send to its or F&G's shareholders in connection with the proposed transaction. Investors and security holders are urged to carefully and entirely read the registration statement and relevant solicitation materials and all other relevant documents, as well as any amendments or supplements to these documents, if and when they become available because they will contain important information about the proposed transaction and related matters. These documents will be available at no charge on the SEC's website at www.sec.gov. In addition, documents will also be available for free from FNF or F&G by contacting Jamie Lillis, Managing Director, Solebury Trout, (203)-428-3223, jlillis@soleburytrout.com or Shannon Devine, Vice President, Solebury Trout, (203)-428-3228, sdevine@soleburytrout.com.

No Offer or Solicitation

This press release is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

View original content to download multimedia:http://www.prnewswire.com/news-releases/fidelity-national-financial-and-fgl-holdings-announce-preliminary-merger-consideration-election-results-301067443.html

SOURCE Fidelity National Financial, Inc.; FGL Holdings

Thursday, 28 May 2020, 19:17

Lilly Receives U.S. FDA Approval of TAUVID(TM) (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease

INDIANAPOLIS, May 28, 2020 /PRNewswire/ -- TAUVID™, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD).¹A neuropathological diagnosis of AD requires the demonstration of the presence of both beta-amyloid neuritic plaques and tau NFTs in the brain. TAUVID is the first and only approved diagnostic agent to image tau NFTs in the brain. Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), developed TAUVID and AMYVID^® (Florbetapir F 18 Injection) to provide physicians with meaningful information on the presence of both pathologies to aid the evaluation of patients suspected of having AD.^1,2

"The use of diagnostic imaging can help patients and their families plan for the future and make informed choices about their health and well-being, in addition to facilitating appropriate patient management for physicians," said Reisa Sperling, M.D., Professor of Neurology of Harvard Medical School, and Director of the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital and Massachusetts General Hospital. "Determining the anatomic distribution and density of tau NFTs in the brain was previously possible only at autopsy. Now we have a way to obtain this important information in patients."

TAUVID was evaluated in two clinical studies. In Study 1, reader interpretations of premortem TAUVID scans from 64 cognitively normal and impaired terminally ill patients who agreed to undergo TAUVID imaging and to participate in a postmortem brain donation program were compared to tau pathology at autopsy based on scoring provided by independent pathologists blinded to scan results. This study met its pre-specified success criteria, with reader sensitivity (95% CI) ranging from 92% (80, 97) to 100% (91, 100) and specificity (95% CI) from 52% (34, 70) to 92% (75, 98) in the primary efficacy cohort. In Study 2, images from the same terminally ill patients as in Study 1 (plus 18 additional terminally ill patients) and 159 patients with cognitive impairment being evaluated for AD (the indicated population) were evaluated by 5 new readers. This study also met the prespecified success criteria for comparison of TAUVID reads to NFT pathology. In addition, inter-reader agreement was evaluated using Fleiss' kappa statistic and found to be 0.87 (95% CI: 0.83, 0.91) across 241 patients in Study 2. The most common adverse reactions reported in clinical trials were headache (1.4%), injection site pain (1.2%), and increased blood pressure (0.8%).^1,3

"The fight against AD requires precise and reliable assessments of the two key pathologies of the disease because clinical assessments alone are limited in their ability to accurately diagnose patients," said Mark Mintun, M.D., vice president of Lilly's pain and neurodegeneration research and development. "History was made with the FDA approval of AMYVID to demonstrate the presence of one of those two pathologies, beta-amyloid plaques. I am excited that TAUVID has now been approved to image tau NFTs, which is the other key pathology, allowing a more comprehensive evaluation of patients. Lilly and Avid Radiopharmaceuticals are committed to bringing innovative AD diagnostics to the patients who need them most."

Availability of TAUVID will initially be limited and will expand in response to commercial demand and payor reimbursement. Lilly remains committed to patients with cognitive impairment associated with Alzheimer's disease and to ensuring patient access to this innovative diagnostic tool. Lilly is supportive of policies that will provide access and coverage for beta-amyloid PET and tau PET imaging agents.

For more than 30 years, Lilly has been engaged in bringing innovative Alzheimer's disease therapies and diagnostics to patients and continues to lead the field in research, which also includes identifying biomarkers to support early detection of the disease.

Indication and Important Safety Information for TAUVID

Indication
TAUVID is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD).

Limitations of Use
TAUVID is not indicated for use in the evaluation of patients for chronic traumatic encephalopathy (CTE).

Important Safety Information

Warnings and Precautions

Risk of Misdiagnosis in Patients Evaluated for Alzheimer's disease
TAUVID does not target β-amyloid, one of two required components of the neuropathological diagnosis of AD. TAUVID performance for detecting tau pathology was assessed in terminally ill patients, the majority of whom had AD dementia with B3 level NFT pathology. TAUVID performance for detecting tau pathology may be lower in patients in earlier stages of the pathological spectrum.

Negative TAUVID Scan
NFTs may be present at levels that qualify for the neuropathological diagnosis of AD (B2 tau pathology in the presence of at least moderate levels of cortical amyloid pathology) in patients with a negative TAUVID scan. Consider additional evaluation to confirm the absence of AD pathology in patients with a negative TAUVID scan.

False Positive TAUVID Scan
Small foci of noncontiguous tracer uptake may lead to a false positive TAUVID scan. Only uptake of tracer in the neocortex should contribute to the interpretation of a positive TAUVID scan.

Risk of Chronic Traumatic Encephalopathy Misdiagnosis
The safety and effectiveness of TAUVID have not been established for patients being evaluated for CTE. Preliminary non-clinical and clinical investigations suggest differences in tau conformation and distribution may limit flortaucipir F 18 binding. Therefore, TAUVID is not indicated for detection of CTE.

Radiation Risk
Diagnostic radiopharmaceuticals, including TAUVID, expose patients to radiation. Radiation exposure is associated with a dose-dependent increased risk of cancer. Ensure safe handling and preparation procedures to protect patients and health care workers from unintentional radiation exposure.

Adverse Reactions
The most common adverse reactions reported in clinical trials were headache (1.4%), injection site pain (1.2%), and increased blood pressure (0.8%).

For Full Prescribing Information, visit http://pi.lilly.com/us/tauvid-uspi.pdf.

Indication and Important Safety Information for AMYVID
AMYVID is a radioactive diagnostic agent for positron emission tomography (PET) imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease and other causes of cognitive decline. A negative AMYVID scan indicates sparse to no neuritic plaques and is inconsistent with a neuropathological diagnosis of Alzheimer's Disease at the time of image acquisition; a negative scan result reduces the likelihood that a patient's cognitive impairment is due to Alzheimer's Disease. A positive AMYVID scan indicates moderate to frequent amyloid neuritic plaques; neuropathological examination has shown this amount of amyloid neuritic plaque is present in patients with Alzheimer's Disease, but may also be present in patients with other types of neurologic conditions as well as older people with normal cognition. AMYVID is an adjunct to other diagnostic evaluations.

Limitations of Use
A positive AMYVID scan does not establish a diagnosis of Alzheimer's Disease or other cognitive disorder. Additionally, the safety and effectiveness of AMYVID have not been established for predicting development of dementia or other neurologic condition, or monitoring responses to therapies.

AMYVID is supplied in 30 mL or 50 mL multidose vials containing 500-1900 MBq/mL Florbetapir F 18.

Important Safety Information

Warnings and Precautions

Risk for Image Misinterpretation and other Errors
Errors may occur in the AMYVID estimation of brain neuritic plaque density during image interpretation.

Image interpretation should be performed independently of the patient's clinical information. The use of clinical information in the interpretation of AMYVID images has not been evaluated and may lead to errors. Other errors may be due to extensive brain atrophy that limits the ability to distinguish gray and white matter on the AMYVID scan as well as motion artifacts that distort the image.

AMYVID scan results are indicative of the brain neuritic amyloid plaque content only at the time of image acquisition and a negative scan result does not preclude the development of brain amyloid in the future.

Radiation Risk
AMYVID, similar to other radiopharmaceuticals, contributes to a patient's overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. Ensure safe handling to protect patients and health care workers from unintentional radiation exposure.

Most Common Adverse Reactions
The most common adverse reactions reported in clinical trials were headache (1.8%), musculoskeletal pain (0.7%), blood pressure increased (0.7%), nausea (0.7%), fatigue (0.5%), and injection site reaction (0.5%).

For Full Prescribing Information, visit http://pi.lilly.com/us/amyvid-uspi.pdf.

About Avid Radiopharmaceuticals
The mission of Avid Radiopharmaceuticals, a wholly owned subsidiary of Lilly, is to discover and develop radiopharmaceuticals and imaging methods that improve global health by accelerating the development of new medicines and enabling a tailored approach to healthcare.

About Eli Lilly and Company
Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at lilly.com and lilly.com/newsroom. P-LLY

This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about TAUVID, a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease. This release reflects Lilly's current beliefs; however, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that the product will prove to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

____________________________________

¹ TAUVID™ Prescribing Information. May 2020.

² AMYVID^® Prescribing Information. December 2019.

³ Fleisher AS, Pontecorvo MJ, Devous MD, et al. Positron Emission Tomography Imaging With [¹⁸F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. JAMA Neurol. Published online April 27, 2020. doi:10.1001/jamaneurol.2020.0528.

TAUVID™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

AMYVID^® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Refer to:	Gina Goodenough; demayo_gina_maria@lilly.com; 646-221-3022 – Media
	Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 – Investor Relations

View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-receives-us-fda-approval-of-tauvid-flortaucipir-f-18-injection-for-use-in-patients-being-evaluated-for-alzheimers-disease-301067441.html

SOURCE Eli Lilly and Company

Thursday, 28 May 2020, 19:09

Susan C. Keating, CEO of WomenCorporateDirectors, Responds to Washington State's New Gender Diversity Board Mandate

NEW YORK, May 28, 2020 /PRNewswire/ -- In response to Washington becoming the next state after California to require public companies to have gender-diverse boards of directors, Susan C. Keating, CEO of the WomenCorporateDirectors Foundation (WCD), says:

"One state mandate is a data point; two is a trend; three is our future.

"Clearly our future is going to include more states mandating at least one woman on boards of publicly traded companies in their state.

"We know that the pipeline of women qualified to serve as directors is vast, experienced, and quickly growing. Every one of our 2,400 members knows at least two more equally qualified women. With the state of Washington's new ruling, we are accelerating our pace into the future."

For more information, please contact Davia Temin at 212.844.9544 or Suzanne Oaks Brownstein at sbrownstein@teminandco.com, or visit www.womencorporatedirectors.org.

About WomenCorporateDirectors Education and Development Foundation, Inc.
The WomenCorporateDirectors Education and Development Foundation, Inc. (WCD) is the only global membership organization and community of women corporate directors. With 2,400 members globally, WCD is the world's largest membership organization of women corporate board members. A 501(c)(3) not-for-profit organization, WCD has 76 chapters around the world. The aggregate market capitalization of public companies on whose boards WCD members serve is over $8 trillion. In addition, WCD members serve on numerous boards of large private and family-run companies globally.

View original content to download multimedia:http://www.prnewswire.com/news-releases/susan-c-keating-ceo-of-womencorporatedirectors-responds-to-washington-states-new-gender-diversity-board-mandate-301067438.html

SOURCE WomenCorporateDirectors Education and Development Foundation, Inc.

Thursday, 28 May 2020, 19:05

Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

SHANGHAI and SAN FRANCISCO, May 29, 2020 /PRNewswire/ -- Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced positive topline results from the NORA study, the Phase 3 randomized, double-blind, placebo-controlled, study of ZEJULA (niraparib) as a maintenance therapy in Chinese patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer (collectively termed as ovarian cancer) who are in a complete or partial response to platinum-based chemotherapy.

The NORA study randomized 265 patients at 2:1 to receive ZEJULA or placebo until disease progression. The study evaluated the efficacy of ZEJULA as a maintenance treatment, with the primary endpoint of progression-free survival (PFS) as assessed by blinded independent central review. The starting dose was individualized at 200 mg except for those with a baseline body weight >77kg and a platelet count >150K/uL in which case the starting dose is 300 mg. The study met its primary endpoint of a statistically significant improvement in progression free survival for patients with ovarian cancer regardless of their biomarker status. The safety profile was consistent with what was observed from the global NOVA study with lower rates of anemia and thrombocytopenia.

"The NORA clinical data in Chinese patients confirmed the compelling clinical profile of ZEJULA and were consistent with the results seen in the global NOVA study," said Dr. Samantha Du, Founder, Chairwoman and Chief Executive Officer. "Importantly, the NORA study demonstrated an individualized starting dose regimen at 200 mg preserved the efficacy while improving safety profile in Chinese patients, particularly with regard to the hematological toxicities. Building on both the promising results of NOVA and Zai Lab's PK study that demonstrated no ethnicity difference between Chinese and global subjects, the NORA study further underscores the promise of ZEJULA as a maintenance therapy for Chinese patients with platinum-sensitive recurrent ovarian cancer."

"The data of the NORA study will have a significant impact on the clinical practice in the treatment of ovarian cancer in China and beyond, as the individualized starting dose regimen has demonstrated clear clinical benefit with improved safety profile," said Dr. Xiaohua Wu, Professor and Chair of Gynecologic Oncology Department of Fudan University Shanghai Cancer Centre. "In addition, the NORA study is the first fully powered, randomized, controlled (RCT) Phase 3 trial ever done in ovarian cancer in China."

The full results from the NORA study will be presented at an upcoming scientific meeting.

About Ovarian Cancer

Ovarian cancer is one of the most common gynecologic cancers in China with more than 52,000 newly diagnosed cases and 23,000 deaths each year. While platinum-based chemotherapy is effective at inducing an initial response in ovarian cancer, the disease will recur in the majority of women. New agents that prolong the duration of response following platinum-based treatment and delay the inevitable relapse of ovarian cancer will benefit patients with ovarian cancer in China.

About ZEJULA (niraparib)

ZEJULA (niraparib) is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. The NMPA is currently reviewing Zai Lab's sNDA under priority review for niraparib as maintenance treatment in patients with first-line ovarian cancer following platinum-based chemotherapy.

Additional development program for niraparib in ovarian cancer by Zai Lab includes an ongoing pivotal study of niraparib as first-line maintenance therapy for Chinese patients with ovarian cancer following platinum-based chemotherapy. Previously, Zai Lab conducted a Phase 1 pharmacokinetic (PK) study of niraparib in Chinese patients with ovarian cancer. This study was published in August 2019 in The Oncologist and demonstrated that the PK profile of niraparib in Chinese patients were comparable to that of patients evaluated in ZEJULA's global PK study.

Zai Lab in-licensed rights to ZEJULA from GSK for Mainland China, Hong Kong and Macau. The NDA for recurrent ovarian cancer was accepted by the NMPA in December 2018, granted priority review status in January 2019 and approved in December 2019. Zai Lab has obtained approval to market ZEJULA in Mainland China, Hong Kong and Macau for maintenance therapy in patients with platinum-sensitive, recurrent ovarian cancer. In March 2020, China NMPA accepted our sNDA for ZEJULA for first-line maintenance treatment of patients with ovarian cancer.

About Zai Lab

Zai Lab (NASDAQ:ZLAB) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China's

pharmaceutical market and address unmet medical needs, Zai Lab's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in our focus areas. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

Zai Lab Forward-Looking Statements

This press release contains statements about future expectations, plans and prospects for Zai Lab, including, without limitation, statements regarding the prospects of and plans for commercializing ZEJULA in China. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact nor are they guarantees or assurances of future performance. Forward-looking statements are based on Zai Lab's expectations and assumptions as of the date of this press release and are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including but not limited to (1) Zai Lab's ability to obtain additional future funding, (2) Zai Lab's results of clinical and pre-clinical development of its drug candidates, (3) the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of Zai Lab's drug candidates, (4) Zai Lab's ability to generate revenue from its drug candidates, (5) the effects of the novel coronavirus (COVID-19) pandemic on general economic, regulatory and political conditions and (6) other factors discussed in Zai Lab's Annual Report on Form 20-F for the fiscal year ended December 31, 2019, filed on April 29, 2020, and its other filings with the Securities and Exchange Commission. Zai Lab anticipates that subsequent events and developments will cause Zai Lab's expectations and assumptions to change and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. These forward-looking statements should not be relied upon as representing Zai Lab's views as of any date subsequent to the date of this press release.

For more information, please contact:

ZAI LAB CONTACTS:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com

SOURCE Zai Lab

Thursday, 28 May 2020, 19:02

TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER, May 28, 2020 /CNW/ -

TSX VENTURE COMPANIES

NXGOLD LTD. ("NXN")
[formerly NXGOLD LTD. ("NXN")]
BULLETIN TYPE: Consolidation, Correction
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2

The formerly name of the Company in the Bulletin dated May 27, 2020, is not correct. It should be NXGOLD LTD.

The Company has consolidated its capital on a ten (10) old for one (1) new basis. The name of the Company has not been changed.

Effective at the opening May 29, 2020, the shares of NxGold Ltd. will commence trading on TSX Venture Exchange on a consolidated basis. The Company is classified as a 'Mineral Exploration/Development' company.

Post - Consolidation
Capitalization:	unlimited	shares with no par value of which
	8,163,228	shares are issued and outstanding
Escrow	0	shares are subject to escrow

Transfer Agent:	Computershare Trust Company of Canada
Trading Symbol:	NXN	(UNCHANGED)
CUSIP Number:	67076M406	(new)

________________________________________

SPARTAN DELTA CORP. ("SDE")
[formerly RETURN ENERGY INC. ("RTN")]
BULLETIN TYPE: Name Change and Consolidation
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

Pursuant to a resolution passed by shareholders on March 4, 2020, the Company has consolidated its capital on a (100) one hundred old for (1) one new basis. The name of the Company has also been changed as follows.

Effective at the opening May 29, 2020, the common shares of Spartan Delta Corp. will commence trading on TSX Venture Exchange, and the common shares of Return Energy Inc. will be delisted. The Company is classified as an 'Oil and Gas Exploration and Development' Company.

Post - Consolidation
Capitalization:	Unlimited		shares with no par value of which
	26,105,517		shares are issued and outstanding
Escrow:	Nil		shares are subject to escrow

Transfer Agent:		Computershare Trust Company of Canada
Trading Symbol:		SDE	(new)
CUSIP Number:		84678A 10 2	(new)

________________________________________

20/05/28 - TSX Venture Exchange Bulletins

TSX VENTURE COMPANIES

DEFENSE METALS CORP. ("DEFN")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced April 29, 2020:

Number of Shares:	680,000 shares
Purchase Price:	$0.11 per share
Warrants:	680,000 share purchase warrants to purchase 680,000 shares
Warrant Exercise Price:	$0.15 for a two year period
Number of Placees:	3 placees

Insider / Pro Group Participation:

Name

Insider=Y /
ProGroup=P

# of Shares

Aggregate Pro Group Involvement

[2 placees]

425,000

Pursuant to Corporate Finance Policy 4.1, Section 1.9(e), the Company has issue a news release announcing dated May 27, 2020, the closing of the private placement and setting out the expiry dates of the hold period(s).

________________________________________

EAST ASIA MINERALS CORPORATION ("EAS")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 6,792,473 shares at a deemed price of $0.05 per share to settle outstanding debt for $339,623.66.

Number of Creditors:

1 Creditor

Insider / Pro Group Participation:
Creditor	Insider=Y / Progroup=P	Amount Owing	Deemed Price per Share	# of Shares
Shellbridge Group Limited (Leo Wong)	Y	$339,623.66	$0.05	6,792,473

The Company shall issue a news release when the shares are issued and the debt extinguished.

________________________________________

FIELDEX EXPLORATION INC. ("FLX")
BULLETIN TYPE: Non-Brokered Private Placement
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement as announced on a news release dated May 8, 2020:

Number of Securities:	7,142,857 common shares
Purchase Price:	$0.07 per common share
Warrants:	7,142,857 common share purchase warrants to purchase 7,142,857 shares
Warrants' Exercise Price:	$0.10 until May 22, 2022
Number of Placees:	24 Placees

Insider / ProGroup Participation:

Name	Insider = Y / ProGroup = P	# of shares
Martin Dallaire	Y	117,857

Finder's Fee:

Raymond James Ltd. received a cash commission of $3,920 and 56,000 non-transferable purchase warrants to purchase 56,000 common shares at a price of $0.10 per share until May 22, 2022.

The Company has confirmed the closing of the Private Placement in a news release dated May 25, 2020.

EXPLORATION FIELDEX INC. («FLX»)
TYPE DE BULLETIN: Placement privé sans l'entremise d'un courtier
DATE DU BULLETIN: Le 28 mai 2020
Société du groupe 2 de TSX Croissance

Bourse de Croissance TSX a accepté le dépôt de la documentation de la société en vertu d'un placement privé sans l'entremise d'un courtier tel qu'annoncé dans un communiqué de presse daté du 8 mai 2020:

Nombre d'actions:	7 142 857 actions ordinaires
Prix :	0,07 $ par action ordinaire
Bons de souscription :	7 142 857 bons de souscription permettant de souscrire à 7 142 857 actions
Prix d'exercice des bons :	0,10 $ jusqu'au 22 mai 2022
Nombre de souscripteurs:	24 souscripteurs

Participation d'initiés / Groupe Pro:

Nom	Initié = Y / Groupe Pro = P	# d'actions
Martin Dallaire	Y	117 857

Honoraire d'intermédiation:

Raymond James Ltd. Ont reçu une commission en espèces e 3 920 $ et 56 000 bons de souscription permettant d'acquérir 56 000 actions ordinaires à un prix de 0,10 $ par actions jusqu'au 22 mai 2022

La société a confirmé la clôture du placement privé dans un communiqué de presse daté du 25 mai 2020.

________________________________________

GIYANI METALS CORP. ("EMM")
BULLETIN TYPE: Private Placement- Non-Brokered
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced on May 19, 2020:

Number of Shares:	15,000,000 common shares
Purchase Price:	CDN$0.08 per share
Warrants:	7,437,499 share purchase warrants to purchase 7,437,499 shares
Warrant Exercise Price:	CDN$0.10 for a three (3) year period
Number of Placees:	16 Placees

Insider / Pro Group Participation:

Name	Insider=Y / ProGroup=P	# of units
Jonathan Henry	Y	375,000
Thomas Horton	Y	312,500

Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.

Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company has issued a new release announcing the closing of the private placement and setting out the expiry dates of the hold period(s).

________________________________________

GTEC HOLDINGS LTD. ("GTEC")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 354,545 shares at a deemed price of $0.14 and 381,818 shares at a deemed price of $0.55 to arm's length creditors to settle outstanding debt for $49,635 and Milestone Payments of $210,000.

Number of Creditors: 3 Creditors

The Company shall issue a news release when the shares are issued and the debt extinguished.

________________________________________

IMAGING DYNAMICS COMPANY LTD. ("IDL")
BULLETIN TYPE: Resume Trading
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

Effective at 9:00 a.m. PST, May 28, 2020, shares of the Company resumed trading, an announcement having been made.

________________________________________

KINTAVAR EXPLORATION INC. ("KTR")
BULLETIN TYPE: Halt
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

Effective at 6:07 a.m. PST, May 28, 2020, trading in the shares of the Company was halted at the request of the Company, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

________________________________________

KINTAVAR EXPLORATION INC. ("KTR")
BULLETIN TYPE: Resume Trading
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

Effective at 9:00 a.m. PST, May 28, 2020, shares of the Company resumed trading, an announcement having been made.

________________________________________

LATTICE BIOLOGICS LTD. ("LBL")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 16,760,000 shares at a deemed price of $0.05 per share to settle outstanding debt for $838,000.

Number of Creditors: 1 Creditor

Insider / Pro Group Participation:

Creditor	Insider=Y / Progroup=P	Amount Owing	Deemed Price per Share	# of Shares
Guy Cook	Y	$838,000	$0.05	16,760,000

The Company shall issue a news release when the shares are issued and the debt extinguished.

________________________________________

LENDIFIED HOLDINGS INC. ("LHI")
BULLETIN TYPE: Regional Office Change
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

Pursuant to Policy 1.2, TSX Venture Exchange has been advised of, and accepted the change of the Filing and Regional Office from Montreal, Quebec to Toronto, Ontario.

________________________________________

LOOP INSIGHTS INC. ("MTRX")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced April 30, 2020:

Number of Shares:	21,130,010 shares
Purchase Price:	$0.10 per share
Warrants:	21,130,010 share purchase warrants to purchase 21,130,010 shares
Warrant Exercise Price:	$0.15 for a two year period
Number of Placees:	46 placees

Insider / Pro Group Participation:

Name	Insider=Y / ProGroup=P	# of Shares
Casey Matson-Dekay	Y	66,667
Robert Anson	Y	650,280
Gavin Lee	Y	182,813
Peter Green	Y	527,500
Dallas Pretty	Y	300,000

Finder's Fee:

An aggregate of $90,680 in cash and 906,800 finders' warrants payable to Echelon Wealth Partners, Canaccord Genuity Corp., Raymond James Ltd. and Mackie Research Capital Corp. Each finder's warrant entitles the holder to acquire one common share at $0.15 for a two year period.

Pursuant to Corporate Finance Policy 4.1, Section 1.9(e), the Company has issued a news release announcing the closing of the private placement and setting out the expiry dates of the hold period(s). Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.

________________________________________

PACIFIC EMPIRE MINERALS CORP. ("PEMC")
BULLETIN TYPE: Property-Asset or Share Purchase Agreement
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation pertaining to an Option Agreement (the "Agreement"), dated May 25, 2020, between Pacific Empire Minerals Corp. (the "Company") and several arm's length parties (collectively, the "Optionors"), whereby the Company has been granted an option to acquire a 100% right, title and interest in certain mineral claims (the "Jean Marie Property") - a copper-gold-silver-molybdenum porphyry project, located in central British Columbia.

Under the terms of the Agreement, the Company will make aggregate cash payments of $675,000, issue an aggregate of 1,500,000 common shares and incur a minimum of $2,700,000 in exploration expenditures over a five-year period to earn the full interest in the Property.

Additionally, upon the exercise of the Option, the Optionors will retain a 2.5% net smelter return (NSR) royalty on the Project, which is purchasable by the Company at any time for $1,500,000. A further 0.25% of the NSR royalty can be purchased at any time for $1,000,000.

For further details, please refer to the Company's news release dated May 27, 2020.

_______________________________________

PORTOFINO RESOURCES INC. ("POR")
BULLETIN TYPE: Property-Asset or Share Purchase Agreement
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing a Property Option Agreement dated May 22, 2020 between Portofino Resources Inc. (the Company) and 1544230 Ontario Inc. (Perry English, the Vendor) whereby the Company may acquire a 100% interest in the Sapawe West Property, located in Schwenger and McCaul Townships, Ontario. Consideration is $62,000 cash and 700,000 common shares over a four year period. The Vendor retains a 1.5% NSR with the Company having the right to purchase 0.75% at any time for $500,000.

________________________________________

SCOTTIE RESOURCES CORP. ("SCOT")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced May 01, 2020:

Number of FT Shares:	14,751,067 flow through shares
Purchase Price:	$0.24 per flow through share
Number of Placees:	39 Placees

Insider / Pro Group Participation:

Name	Insider=Y / Pro-Group=P	# of Shares
Stephen Sulis	Y	10,000
Aggregate Pro-Group Involvement [1 Placee]	P	50,000

Finder's Fee:
Qwest Investment Fund Management Ltd.	$5,990.40 cash;	24,960 warrants
PI Financial Corp.	$1,440.00 cash;	6,000 warrants
Haywood Securities Inc.	$5,999.04 cash;	24,996 warrants
Canaccord Genuity Corp.	$78,000.00 cash;	325,000 warrants
Mackie Research Capital Corporation	$91,200.00 cash;	380,000 warrants
Mackie Research Capital Corporation	$2,999.52 cash;	12,498 warrants

Finder Warrant Initial Exercise Price:	$0.24

Finder Warrant Term to Expiry:	Exercisable for two years from closing

The above information is a summary only. Neither TMX Group Limited nor any of its affiliated companies guarantee the accuracy or completeness of the information contained in this document. Readers should consult the issuer's continuous disclosure record for complete details of the transaction.

________________________________________

SILVER RANGE RESOURCES LTD. ("SNG")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced February 11, 2020:

Number of Shares:	5,225,000 shares
Purchase Price:	$0.08 per share
Warrants:	5,225,000 share purchase warrants to purchase 5,225,000 shares
Warrant Exercise Price:	$0.16 for a two year period
Number of Placees:	7 placees

Insider / Pro Group Participation:

Name	Insider=Y / ProGroup=P	# of Shares
Strategic Metals Ltd.	Y	2,000,000

Pursuant to Corporate Finance Policy 4.1, Section 1.9(e), the Company has issued a news release dated April 6, 2020, announcing the closing of the first tranche private placement and a news release dated May 28, 2020, announcing the closing of the final tranche private placement and setting out the expiry dates of the hold period(s).

________________________________________

SKRR EXPLORATION INC. ("SKRR")
BULLETIN TYPE: Property-Asset or Share Purchase Agreement
BULLETIN DATE: May 28, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing an Option Agreement dated May 20, 2020 between SKRR Exploration Inc. (the Company) and Taiga Gold Corp. (the Vendor) whereby the Company may acquire a 51% interest in the Leland Property located 100km east of La Ronge, Saskatchewan. Consideration is $500,000, 1,000,000 common shares and $1,500,000 in exploration expenditures prior to December 31, 2022. The Company may acquire an additional 24% interest in exchange for an additional 500,000 common shares and $1,500,000 in exploration expenditures prior to December 31, 2023. The Vendor retains a 2% NSR with the Company having the right to purchase 1.0% for $1,000,000.

________________________________________

NEX COMPANY :

FIRESWIRL TECHNOLOGIES INC. ("FSW.H")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: May 28, 2020
NEX Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 1,506,328 shares to settle outstanding debt for $203,354.40.

Number of Creditors: 7 Creditors

Insider / Pro Group Participation:

Creditor	Insider=Y / Progroup=P	Amount Owing	Deemed Price per Share	# of Shares
		$	$
Gurdeep Bains	Y	30,000	0.135	222,222
Rana Vig	Y	30,000	0.135	222,222

The Company shall issue a news release when the shares are issued and the debt extinguished.

________________________________________

SOURCE TSX Venture Exchange

Thursday, 28 May 2020, 19:00

Endofotonics Raises S$12 million in Series B Funding for the Commercialization of its AI Powered Medical Device to Support Clinicians in the Real Time Detection of Early Stomach Cancer

SINGAPORE, May 29, 2020 /PRNewswire/ -- Endofotonics announced earlier today that it has secured an investment of S$12 million led by eminent healthcare investors Mr Tony Tan Choon Keat, Chairman of Singapore Medical Group (SMG) and Founding Managing Director of Parkway Holdings, and Dr Beng Teck Liang, Chief Executive Officer and Executive Director of SMG. The funds will be used to drive commercialization of its early gastric cancer detection system, SPECTRA IMDx™, in Asia Pacific and to expand the coverage of its cancer detection technology to other organs.

Endofotonics Pte Ltd is a MedTech company founded in 2013 by Professor Lawrence Ho, a senior consultant gastroenterologist with the National University Hospital in Singapore and is currently led by CEO, Mr Peter Cheng, COO, Mr Chew Jing Ming and Lead Optical Specialist Dr Harsono Cahyadi.

The 12-men core team has successfully developed the SPECTRA IMDx™ system which enables real time detection of early gastric cancer during endoscopy. This is a world's first in miniaturizing and embedding Raman spectroscopy within an optical probe which can fit through an endoscope. Coupled with proprietary artificial intelligence, SPECTRA IMDx™️ helps doctors identify early cancer lesions by analyzing molecular changes that typically occur beyond the stomach lining. Such cancer lesions may not be easily detectable visually. SPECTRA IMDx™ is a new and unique solution for timely medical intervention.

"Leveraging on Raman spectroscopy, we have developed a platform technology that can be applied to multiple organs, giving clinicians real time information to make decisions then and there. Not only can this be applied to early cancer detection, it can be further developed to identify safety margins for dissections or resections," said Mr Peter Cheng.

Since its inception in 2013, Endofotonics has been well supported by Singapore-based funding and its first angel investor was Professor Lui Pao Chuen, NRF Adviser and former Chief Defence Scientist of the Singapore Armed Forces who continues to join in follow-up investments. Endofotonics secured its Series A funding in 2016 from ZIG Ventures and SEEDS Capital^[1], the investment arm of Enterprise Singapore, under the Startup SG Equity scheme. ZIG Ventures proactively worked with Professor Lawrence Ho to build Endofotonics and organized a core team of innovators and experienced industry professionals to establish its go-to-market strategy. Enterprise Singapore has been an effective conduit in helping Endofotonics gain access to global talent, facilitating global engagements with top hospitals and enterprises in Europe and China, as well as supporting the company in its incorporation of its wholly owned subsidiary in Shanghai.

"In spite of the COVID-19 situation, Endofotonics has been able to secure significant funding from prominent local investors, due to their compelling proposition in advancing the early detection of gastric cancer. The investment round also validates the successful combination of cutting-edge medical and engineering research, driven by a strong team with core capabilities anchored here in Singapore. Enterprise Singapore and SEEDS Capital will continue to support Endofotonics in commercialising their device and capturing new opportunities in Asia Pacific and beyond," said Mr Ted Tan, Chairman of SEEDS Capital and Deputy Chief Executive Officer of Enterprise Singapore.

"Endofotonics' Spectra IMDx™ is the leading Raman cancer diagnostic tool for gastric cancer wholly conceived and created in Singapore. We are pleased to be part of this exciting journey to further develop and bring to market this innovative technology to the rest of the world," said Dr Beng Teck Liang.

"What the team has developed is the forefront in gastric and oesophageal cancer diagnosis and treatment applications. We are excited to support them in this journey," said Mr Tony Tan.

In line with the new injection of funds, Endofotonics' present Board comprises of Board Chairman Mr Sim Giok Lak (Chairman of ZIG Ventures), and includes Mr Peter Cheng, Mr Tony Tan, Dr Beng Teck Liang, Prof Lawrence Ho, Prof Lui Pao Chuen , Mr Jen Kwong Hwa (Ex- Managing Director of Micron Singapore), and Mr Sim Kok Hwee (CEO of ZIG Ventures).

Endofotonics also targets to launch its SPECTRA IMDx™ system in Europe and selected countries in Asia in 2021. The addressable market potential of the system is estimated to be more than US$5 billion.

[1] SEEDS Capital is the investment arm of Enterprise Singapore, the government agency championing enterprise development. It manages the funds under Startup SG Equity, which catalyses private sector investments into innovative, Singapore-based tech startups.

About Endofotonics

Endofotonics is a medtech organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients. Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.

About Singapore Medical Group

Incorporated in 2005, Singapore Medical Group (SMG) is a public-listed organisation with a network of private specialist providers across diverse medical disciplines, and complementary diagnostic imaging and health screening services. With a vision to become Asia's best healthcare network, SMG embarked on a rapid expansion drive in 2013 and has continued since to expand beyond Singapore and establish its presence in Indonesia, Vietnam and Australia. Within Singapore, SMG has more than 30 clinics strategically located in central Singapore and mature heartland estates. The central clinics are situated at Paragon, Mount Elizabeth Novena Specialist Centre, Gleneagles Medical Centre, Downtown Gallery, while the heartland clinics are situated at Bedok, Bishan, Hougang, Jurong, Novena, Tiong Bahru and Toa Payoh. This hub-and-spoke model provides ease of access to our patients and is aligned with our promise to provide patient-centred care to every individual. To further elevate the patient experience, HiDoc, a telemedicine application was created in 2019 to enable virtual consultation and digital storage of the individual's health records.

About ZIG Ventures

ZIG is a medtech venture investment and commercialisation organisation based in Singapore. Established in 2014 as the corporate venturing arm of Zicom Group, a diversified engineering and manufacturing company, it was demerged from Zicom Group in 2018 to focus as a standalone investment organisation. ZIG is a co-investment partner of Enterprise Singapore and focuses on identifying early stage medtech innovation that is transformational, provides significant improvements in patients' clinical outcomes, and creates value for the healthcare ecosystem. Its portfolio companies are in the areas of oncology, healthcare analytics, ophthalmology, and life sciences sectors.

Contact Info

For more information, please contact

Mr. Chew Jing Ming
+65 6507 0364
contact@endofotonics.com

SOURCE Endofotonics

Thursday, 28 May 2020, 19:00

Insoluble Dietary Fibers Market to Hit $5 Billion by 2026, Says Global Market Insights, Inc.

SELBYVILLE, Delaware, May 28, 2020 /PRNewswire/ -- Global insoluble dietary fibers market revenue is poised to cross USD 5 billion by 2026, according to a new research report by Global Market Insights, Inc. Rising consumer health consciousness and demand for demand for functional foods globally will escalate the demand for low calorie products, thus fostering overall market growth.

Increasing government policies and initiatives to improve the nutrition intake among people will fuel insoluble dietary fibers industry demand. Substantial investments directed toward R&D by leading companies have resulted in enhancement of shelf life, improved texture, and heat stability in food and beverage products. Strict nutrition facts labelling and standards on packaged food items that govern the suitability of dietary fiber claims will help in improving the quality of products.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2874

Fruits & vegetables emerge as prominent sources of insoluble dietary fibers accounting for over 40% market share in 2019. Fruits and vegetables such as spinach, carrots, broccoli, cauliflower, cabbage, kale, apples, banana, mango, orange, and dark leafy vegetables. are excellent sources of insoluble fiber. These essential substances help to promote bowel health, supports insulin sensitivity and helps reduce your risk of diabetes. Technological advancements enabling the utilization of fruits & vegetable waste to derive dietary fiber will have a positive impact on market outlook.

Some major findings of the insoluble dietary fibers market report include:

Rising prevalence of obesity, cholesterol problems, diabetes, gastrointestinal, and other health issues among the young populace has boosted the demand for low calorie and healthy food products. This will support global industry growth over the forecast period.
Comprehensive functional properties including bacterial fermentation, adsorptive functions, water-holding capacity and as thickening agents in dairy applications will foster product demand.
Increasing consumer awareness of fiber intake levels for infants owing to a recommendation from government organizations will spur industry size.
Some of the key market players manufacturing insoluble dietary fibers are ADM, Cargill, Ingredion Incorporated, Tate & Lyle, Roquette Freres, SunOpta, Grain Processing Corporation, DuPont Danisco and J. Rettenmaier & Sohne Gmbh.
Market statistics for insoluble dietary fibers market for beverages application incurred the highest CAGR and the sector is further anticipated to witness significant gains due to escalating demand for nutrient rich yogurt, milk & other beverage products for maintaining proper gut health of consumers.
Asia Pacific region acquired significant share in the global insoluble dietary fibers industry.

Browse key industry insights spread across 300 pages with 242 market data tables and 16 figures & charts from the report, "Global Insoluble Dietary Fibers Market Statistics By Product (Cellulose, Hemicellulose, Chitin & Chitosan, Lignin, Fiber/Bran, Resistant Starch), Source (Cereals & Grains, Fruits & Vegetables), Application (Food [Bakery, Breakfast Cereals & Snacks, Confectionery, Dairy, Meat Products, Infant Food], Beverages, Pharmaceutical, Companion Animal Nutrition), Industry Analysis Report, Regional Outlook, Competitive Market Share & Forecast, 2015 – 2026" in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/insoluble-dietary-fibers-market

Insoluble dietary fibers market from pharmaceutical application is anticipated to witness over 8% CAGR up to 2026, due to increasing R&D investments and product development of pharmaceutical supplements. Consumer focus to maintain fitness and regulate body weight has enhanced product penetration in the dietary supplement industry. For instance, both professional athletes and fitness enthusiasts have increased the consumption of fiber-fortified dietary products to aid weight management and improve digestion.

Asia Pacific insoluble dietary fibers market is anticipated to witness over 7% CAGR through 2026. Favourable demographic scenario, which has both young and geriatric populace seeking healthy alternatives in terms of diet and supplementation to prevent diseases will proliferate business opportunities. Besides, rising disposable income, increasing consumer expenditure level, and changing living standards due to rapid urbanization in major metropolitan cities will escalate the industry landscape in the region.

Manufacturers are engaged in strategic expansion initiatives including partnerships, acquisitions, joint ventures, R & D activities to improve their market share and compete with major players. For instance, in February 2019, Archers Daniels Midland announced the completion of acquisition of Neovia for USD 1.8 billion. This will help the company to expand its animal nutrition product portfolio, improve its R&D capabilities, and enable development of animal nutrition ingredients and solutions. These factors will have a positive impact on market statistics.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2874

Browse Related Reports:

Dietary Fibers Industry By Application (Food, Beverages, Pharmaceutical, Companion Animal Nutrition), Product (Soluble, Insoluble), Source (Cereals & Grains, Fruits & Vegetables), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026
https://www.gminsights.com/industry-analysis/dietary-fibers-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: +1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Logo: https://mma.prnewswire.com/media/661916/GMI.jpg

Thursday, 28 May 2020, 19:00

CNW Media Daybook for Friday, May 29, 2020

TORONTO, May 28, 2020 /CNW/ - ALL TIMES ARE LOCAL

FRIDAY, MAY 29

ONTARIO

TIME:	10:00
EVENT:	The Prime Minister will address Canadians on the COVID-19 situation
CITY:	OTTAWA
LOCATION:	Rideau Cottage, 1 Sussex Drive
URL:	https://www.newswire.ca/news-releases/media-advisory-prime-minister-s-itinerary-for-friday-may-29-2020-809936050.html

SOURCE CNW Group - Media Daybook

Thursday, 28 May 2020, 19:00

Universities Space Research Association Elects KAIST and Seoul National University to Membership

COLUMBIA, Maryland, May 29, 2020 /PRNewswire/ -- The Korea Advanced Institute of Science and Technology (KAIST) and Seoul National University (SNU), two distinguished South Korean universities, have joined the ranks of Universities Space Research Association (USRA), bringing the Association to a total of 113 universities. They were elected by USRA's current university members on May 4, 2020.

The eligibility criteria for USRA membership includes demonstrated significant contributions in space or aerospace research fields by faculty, and a substantial commitment to a course of studies and dissertation research leading to the doctorate in one or more related fields. Members participate in the governance of USRA through the election of members to the USRA Board of Trustees and establishment of the Association's bylaws.

Dr. Jeffrey A, Isaacson, USRA's President and CEO, said, "We are delighted to welcome these renowned universities as members. The expertise they bring broadens our collective strength in space-related science and technology, worldwide. We look forward to their active engagement with, and contributions to, our Association."

Korea Advanced Institute of Science and Technology (KAIST) – Founded in 1971, KAIST is the Republic of Korea's premier science and technology university. Its Satellite Technology Research Center developed Korea's first satellite, in 1992, and has developed, launched, and operated satellites for Earth observation and space science. The KAIST Aerospace Engineering department is planning multiple space missions with CubeSats for laser communications, Earth imaging, atmospheric measurements, and formation flying.

Seoul National University (SNU) – Founded in 1946, SNU has a strong aerospace engineering program, which includes research with interdisciplinary links to space science, propulsion and satellite technology. The Interdisciplinary Program for Space Systems focuses on education and research capabilities in the field of launch vehicles, space materials, satellites and their applications, and space risk. SNU also heads a space education network consisting of domestic universities and research institutes.

About USRA
Founded in 1969, under the auspices of the National Academy of Sciences at the request of the U.S. Government, the Universities Space Research Association (USRA) is a nonprofit corporation chartered to advance space-related science, technology, and engineering. USRA operates scientific institutes and facilities, and conducts other major research and educational programs, under Federal funding. USRA engages the university community and employs in-house scientific leadership, innovative research and development, and project management expertise. More information about USRA is available at www.usra.edu.

PR Contact:
Suraiya Farukhi, Ph.D.
sfarukhi@usra.edu
410-740-6224; 443-812-6945

Logo - https://mma.prnewswire.com/media/808782/USRA___Logo.jpg

SOURCE Universities Space Research Association

Thursday, 28 May 2020, 18:59

SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report

VANCOUVER, May 28, 2020 /CNW/ - SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly (collectively the "Syndicate"), announced that they have filed an early warning report related to the participation of the Syndicate in a private placement offering (the "Offering") of units (the "Units") of Comstock Metals Ltd. (TSX-V:CSL) (the "Issuer"). Under the terms of the Offering, the Syndicate purchased 1,691,240 Units from the Issuer at a price of $0.075 per Unit. Each Unit was comprised of one common share (the "Common Shares") and one share purchase warrant (the "Warrants") entitling the holder to purchase one additional Common Share of the Issuer for a period of 36 months after the closing of the Offering at a price of $0.075.

Upon completion of the Offering, the Syndicate beneficially owns and has control of 4,843,641 Common Shares of the Issuer, as well as Warrants to acquire a further 2,043,640 Common Shares, which represents approximately 28.72% of the issued and outstanding Common Shares as calculated in accordance with National Instrument 62-104 Take-Over Bids and Insider Bids.

The forgoing numbers are reported on a post-consolidation basis with reference to the 5 to 1 share consolidation of the Issuer's issued and outstanding Common Shares on a that was completed on May 26, 2020.

The Units were acquired for investment purposes only by the Syndicate. The Syndicate's view of the Issuer and investment may change, depending on market and other conditions, or as future circumstances may dictate, from time to time. The Syndicate, on an individual or joint basis, may increase or dispose of some or all of their ownership in the Issuer or each may continue to hold its current position.

This news release is being issued in accordance with National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the filing of an early warning report dated May 27, 2020. A copy of the early warning report relating to the Syndicate's participation in the Offering will be available under the Issuer's profile on the System for Electronic Document Analysis and Review ("SEDAR") at www.sedar.com.

Forward Looking Statements:

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Syndicate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Syndicate to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Syndicate believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Syndicate assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

SOURCE SJ Strategic Investments LLC

Thursday, 28 May 2020, 18:54

Notice to the media - Ministers and Government of Canada officials to hold a news conference on coronavirus disease (COVID-19)

OTTAWA, May 28, 2020 /CNW/ - Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

Date
May 29, 2020

Time
9:15 AM (EDT)

Location
West Block, Room 225
Parliament Hill
Wellington Street, Ottawa, Ontario

The media availability will also be held by teleconference.
Toll-free dial-in number (Canada/US): 1-866-805-7923
Local dial-in number: 613-960-7518

Participant passcode: 7221615#

SOURCE Public Health Agency of Canada

Thursday, 28 May 2020, 18:30

Fieldex Exploration Grant Options

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

ROUYN-NORANDA, QC, May 28, 2020 /CNW Telbec/ - Fieldex Exploration Inc. (TSXV: FLX) (Frankfurt: F7E1) ("Fieldex") announces that its Board of Directors today granted stock options in respect of an aggregate of 1,300,000 common shares to Fieldex's Directors, Officers and two consultants. The exercise price of the options is $0.12 per share, which is higher to the closing price of Fieldex's common shares on the TSX Venture Exchange on Thursday May 28, 2020. The options vest immediately and will expire in ten years. The options were granted under Fieldex's Stock Option Plan.

About Fieldex

Fieldex is a mineral resource company actively exploring in Québec on acquiring and exploring precious metals deposits located in the province of Québec.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.

SOURCE Fieldex Exploration Inc.

Thursday, 28 May 2020, 18:30

Solaris Completes C$20 Million Private Placement

VANCOUVER, May 28, 2020 /CNW/ - Solaris Resources Inc. ("Solaris" or the "Company") has completed a non-brokered private placement financing raising gross proceeds of C$20 million (the "Private Placement").

Pursuant to the Private Placement, Solaris issued 25,000,000 units of the Company at a price of C$0.80 per unit, with each unit consisting of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire one common share at a price of C$1.20 for a period of three years.

The proceeds from the Private Placement will be used to advance exploration efforts at the Company's properties, including a comprehensive geophysical survey and expanded drilling program at Warintza, and for general and working capital purposes.

The Private Placement was fully subscribed by senior management, including Richard Warke, Executive Chairman, and Daniel Earle, President and CEO, and by Equinox Gold, a strategic partner to the Company.

Mr. Earle commented, "We greatly appreciate the steadfast support of our largest shareholders amidst the market turmoil brought on by the COVID-19 pandemic. With approximately C$25 million of cash on hand, the company is well financed to responsibly resume exploration at Warintza, and to accelerate our drilling program, with strict protocols in place to protect the health and safety of our workers and partner communities."

On behalf of the Board of Solaris Resources Inc.

"Daniel Earle"

President & CEO, Director

About Solaris Resources Inc.

Solaris is advancing a portfolio of copper and gold assets in the Americas, which includes: a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru; exposure to US$130M spending / 5-yrs through a farm-out agreement with Freeport-McMoRan on the Ricardo Project in Chile; and significant leverage to increasing copper prices through the 60%-interest in the development-stage La Verde joint-venture project with Teck Resources in Mexico. Solaris Resources operates as a reporting issuer, however, is not currently listed on a designated stock exchange.

Cautionary Notes and Forward-looking Statements

This document contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively "forward-looking statements"). The use of the words "intention", "will", "may", "can", and similar expressions are intended to identify forward-looking statements. Although Solaris believes that the expectations reflected in such forward-looking statements and/or information are reasonable, undue reliance should not be placed on forward-looking statements since Solaris can give no assurance that such expectations will prove to be correct. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements, including the risks, uncertainties and other factors identified in Solaris' Management's Discussion and Analysis for the year ended December 31, 2019 available at www.sedar.com. Furthermore, the forward-looking statements contained in this news release are made as at the date of this news release and Solaris does not undertake any obligations to publicly update and/or revise any of the included forward-looking statements, whether as a result of additional information, future events and/or otherwise, except as may be required by applicable securities laws.

SOURCE Solaris Resources Inc.

Thursday, 28 May 2020, 18:27

Fiera Capital Corporation announces the election of directors

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR
DISSEMINATION IN THE UNITED STATES/

MONTREAL, May 28, 2020 /CNW Telbec/ - Fiera Capital Corporation ("Fiera Capital" or the "Company"), a leading independent asset management firm, announces that all nominees listed in the management information circular dated April 8, 2020 were elected as directors of the Company at the annual general and special meeting of shareholders held on May 28, 2020 (the "Meeting").

Each of the four (4) Class A directors proposed for election at the Meeting was elected by a majority of the votes cast by the holders of Class A Subordinate Voting Shares of the Corporation and by the proxyholders of that class. The voting results for the election of the Class A directors are the following:

Class A Directors	Votes For		Votes Withheld
Class A Directors	#	%	#	%
Geoff Beattie	27,329,171	64.58	14,990,831	35.42
Gary Collins	39,570,090	93.50	2,749,912	6.50
Jean Raby	39,339,856	92.96	2,980,146	7.04
David R. Shaw	39,539,684	93.43	2,780,318	6.57

Each of the eight (8) Class B directors proposed for election at the Meeting was elected by the sole holder of Class B Special Voting Shares, Fiera Capital L.P. The voting results for the election of the Class B directors are the following:

Class B Directors	Votes For		Votes Withheld
Class B Directors	#	%	#	%
Réal Bellemare	19,412,401	100	0	0
Jean-Guy Desjardins	19,412,401	100	0	0
Vincent Duhamel	19,412,401	100	0	0
Nitin N. Kumbhani	19,412,401	100	0	0
Raymond Laurin	19,412,401	100	0	0
Jean C. Monty	19,412,401	100	0	0
Lise Pistono	19,412,401	100	0	0
Norman M. Steinberg	19,412,401	100	0	0

Shareholders and members of the public who were unable to attend the live Meeting are invited to listen to the archived webcast, which will be available in the Investor Relations section of the Company's website for 365 days following the meeting.

About Fiera Capital Corporation

Fiera Capital is a leading independent asset management firm with approximately C$158.1 billion in assets under management as of March 31, 2020. The Company provides institutional, retail and private wealth clients with access to full-service integrated money management solutions across traditional and alternative asset classes. Clients and their portfolios derive benefit from Fiera Capital's depth of expertise, diversified offerings and outstanding service. Fiera Capital trades under the ticker FSZ on the Toronto Stock Exchange. www.fieracapital.com

In the U.S., asset management services are provided by the Company's U.S. affiliates who are investment advisers that are registered with the U.S. Securities and Exchange Commission (SEC). Registration with the SEC does not imply a certain level of skill or training. For details on the particular registration of, or exemptions therefrom relied upon by, any Fiera Capital entity, please consult this webpage.

Additional information about Fiera Capital Corporation, including the Company's annual information form, is available on SEDAR at www.sedar.com.

SOURCE Fiera Capital Corporation

all prices

Live stock markets prices

Latest news

Thunderbird Entertainment Reports on Company Record Third Quarter Results

AEEC-Google COVID-19 Solutions

Kaiser Permanente Extends COVID-19 Cost Waiver Through Dec. 31, 2020

NexPoint Hospitality Trust To Postpone Reporting First Quarter 2020 Financial Results And MD&A Due To COVID-19 Related Delays

Pacific Workers', The Lawyers for Injured Workers Expands Amid COVID with Stockton & Sacramento Offices

Several Puerto Rico Golf Courses And Resorts Reopen

Fidelity National Financial And FGL Holdings Announce Preliminary Merger Consideration Election Results

Lilly Receives U.S. FDA Approval of TAUVID(TM) (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease

Susan C. Keating, CEO of WomenCorporateDirectors, Responds to Washington State's New Gender Diversity Board Mandate

Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

TSX Venture Exchange Stock Maintenance Bulletins

Endofotonics Raises S$12 million in Series B Funding for the Commercialization of its AI Powered Medical Device to Support Clinicians in the Real Time Detection of Early Stomach Cancer

Insoluble Dietary Fibers Market to Hit $5 Billion by 2026, Says Global Market Insights, Inc.

CNW Media Daybook for Friday, May 29, 2020

Universities Space Research Association Elects KAIST and Seoul National University to Membership

SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report

Notice to the media - Ministers and Government of Canada officials to hold a news conference on coronavirus disease (COVID-19)

Fieldex Exploration Grant Options

Solaris Completes C$20 Million Private Placement

Fiera Capital Corporation announces the election of directors

Verified accounts

🔥 Mataf Trading account

satelysfx

A personalized analysis of your trading account

History of a trading strategy

Trading Week (May 25 to May 31)

Customized chart

How does mataf work?

CSV File

Timezone Setting

Indexes not updating

MT4 Offline chart?

Portfolio with chart

Loading Chart Layout

Rates not updating?

Volitility Pips timing

How to convert Bitcoin to USD

MULTIPLE CHARTS

Correlation

Creating a template for 8 charts

leverage

Correrations

Do we have currency strength meter, here on Mataf?

EURUSD

indices des devises

Installer l'EA MT4 pour connecter son compte à Mataf

Comment sont calculés vos graphiques d'indices ?

Société de gestion de capital pour traders

Installer l'EA MT5 pour connecter son compte à Mataf

besoin de renseignement

Etude du drawdown

Win Rate (taux de positions gagnantes)